• 

  Next-Generation Alzheimer’s Drugs Show Mixed Results at AAIC
• 

  Should People Without Symptoms Get an Alzheimer’s Blood Test?
• 

  FDA Approves At-Home Injectable Leqembi for Early Alzheimer’s
• 

  THC/CBD Shows Promise for Treating Agitation in Late-Stage Alzheimer’s
• 

  Alzheimer’s Clinical Trials Explained
• 

  Huntington’s Gene Therapy Back on Track to File for FDA Approval
• 

  Alzheimer’s Treatments 2026: Here’s Every FDA-Approved Therapy and What Comes Next